BioLegend Patents – Key Insights and Stats

BioLegend has a total of 61 patents globally, out of which 15 have been granted. Of these 61 patents, more than 63% patents are active. The USA is where BioLegend has filed the maximum number of patents, followed by Europe and China. The USA seems to be the main focused R&D center and is also the origin country of BioLegend.

BioLegend is the subpart of PerkinElmer was founded in the year 2002. The company develops and manufactures antibodies and reagents for biomedical research. The Company provides products such as immunology antibodies, cytokines and chemokines, immunoassays, cell biology antibodies, isotype controls, secondary reagents, buffers, substrates, and media additives. Biolegend serves customers worldwide.

Do read about some of the most popular patents of BioLegend which have been covered by us in this report and also you can find BioLegend’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over BioLegend’s patent portfolio.

How many patents does BioLegend have?

BioLegend has a total of 61 patents globally. These patents belong to 21 unique patent families. Out of 61 patents, 39 patents are active.

How Many Patents did BioLegend File Every Year?

BioLegend Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantBioLegend Applications FiledBioLegend Patents Granted

How many BioLegend patents are Alive/Dead?

Worldwide Patents

BioLegend Patents Portfolio

How Many Patents did BioLegend File in Different Countries?

BioLegend Worldwide Patents

Countries in which BioLegend Filed Patents

United States Of America12

Where are the Research Centres of BioLegend Patents Located?

Research Centres of BioLegend Patents

Best BioLegend Patents

US20040248325A1 is the most popular patent in the BioLegend portfolio. It has received 104 citations so far from companies like Quanterix Corporation, General Electric Company, and 10X Genomics.

What Percentage of BioLegend US Patent Applications were Granted?

BioLegend (Excluding its subsidiaries) has filed 10 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 66.6%.

Below are the key stats of BioLegend patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for BioLegend?

Law FirmTotal ApplicationsSuccess Rate
Kilpatrick Townsend & Stockton Llp9100.00%
Grant Ip Inc10.00%

What are BioLegend key innovation segments?

What Technologies are Covered by BioLegend?

The chart below distributes patents filed by BioLegend in different countries on the basis of the technology protected in patents. It also represents the markets where BioLegend thinks it’s important to protect particular technology inventions.

R&D Focus: How has BioLegend‘s search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by BioLegend?

Related Articles

Weo Llc Patents – Insights & Stats (Updated 2024)

Weo Llc has a total of 47 patents globally, out of which 9 have been granted. Of these 47 patents, more than 87% patents are active. The United States of America is where Weo Llc has filed the maximum number of patents, followed by Brazil and Australia. Parallelly, France seems

Read More »

Fortephest Patents – Insights & Stats (Updated 2024)

Fortephest has a total of 23 patents globally. Of these 23 patents, more than 91% patents are active. Argentina is where Fortephest has filed the maximum number of patents, followed by New Zealand and Australia. Parallelly, The United States of America seems to be the main focused R&D center and

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.